20240041645. MEDICAMENT THERAPY DELIVERY SYSTEMS AND METHODS simplified abstract (W. L. Gore & Associates, Inc.)

From WikiPatents
Jump to navigation Jump to search

MEDICAMENT THERAPY DELIVERY SYSTEMS AND METHODS

Organization Name

W. L. Gore & Associates, Inc.

Inventor(s)

Jérôme S. Conia of Phoenix AZ (US)

Jeffrey C. Towler of Wilmington DE (US)

MEDICAMENT THERAPY DELIVERY SYSTEMS AND METHODS - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240041645 titled 'MEDICAMENT THERAPY DELIVERY SYSTEMS AND METHODS

Simplified Explanation

The patent application describes a medicament delivery device designed to deliver a medicament to ocular tissue over a specific time period. The device consists of a tube with a microporous core and a body portion that has an internal reservoir. The external surface of the body portion includes a port for the initial passage of the medicament from the reservoir. The tube length defines a second passage for the medicament from one end of the tube to the other. The first end of the tube is connected to the port to receive the medicament from the reservoir, while the second end is positioned at a distance from the first end to deliver the medicament to the ocular tissue. The microporous core, located along at least a portion of the tube length, has a porosity that controls the flow rate of the medicament through the second passage.

  • The device is designed to deliver a medicament to ocular tissue over a specific time period.
  • It includes a tube with a microporous core and a body portion with an internal reservoir.
  • The external surface of the body portion has a port for the initial passage of the medicament.
  • The tube length defines a second passage for the medicament from one end of the tube to the other.
  • The first end of the tube is connected to the port to receive the medicament from the reservoir.
  • The second end of the tube is positioned to deliver the medicament to the ocular tissue.
  • The microporous core controls the flow rate of the medicament through the second passage.

Potential Applications:

  • Controlled delivery of medicaments to ocular tissue.
  • Treatment of ocular diseases or conditions requiring sustained release of medication.
  • Improved patient compliance with medication regimens.

Problems Solved:

  • Ensures precise and controlled delivery of medicaments to ocular tissue.
  • Eliminates the need for frequent administration of medication.
  • Reduces the risk of over or under-dosing.

Benefits:

  • Provides a convenient and effective method for delivering medication to ocular tissue.
  • Ensures consistent and sustained release of medication.
  • Improves patient comfort and compliance.
  • Reduces the risk of medication errors.


Original Abstract Submitted

medicament delivery devices are provided for metering delivery of a medicament over a time period to an ocular tissue. the device includes a tube, a microporous core, and a body portion with an external surface defining an internal reservoir. external surface defines a port of the body portion disposed to facilitate a first passage of the medicament from the reservoir. tube length defines a second passage of the medicament from the first end to the second end of the tube. first end is coupled to the port to receive the first passage of the medicament from the reservoir. second end is disposed at a distance from the first end to deliver the medicament to the ocular tissue. microporous core is disposed in the lumen along at least a portion of the tube length and has a porosity that meters the second passage of the medicament.